Aflac (NYSE:AFL) Director Sells $1,713,808.70 in Stock

Aflac Incorporated (NYSE:AFL) Director Charles Lake II sold 15,590 shares of the stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $109.93, for a total transaction of $1,713,808.70. Following the completion of the sale, the director owned 62,237 shares in the company, valued at $6,841,713.41. The trade was a 20.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Aflac Trading Down 0.8%

Shares of NYSE:AFL opened at $108.73 on Monday. The company has a market capitalization of $56.14 billion, a PE ratio of 15.80, a PEG ratio of 3.56 and a beta of 0.66. Aflac Incorporated has a 12-month low of $96.95 and a 12-month high of $119.32. The business has a 50 day moving average of $111.63 and a two-hundred day moving average of $110.33. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $1.57 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.12). The business had revenue of $4.28 billion during the quarter, compared to analysts’ expectations of $4.45 billion. Aflac had a net margin of 21.24% and a return on equity of 14.35%. The firm’s quarterly revenue was down 9.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.57 earnings per share. As a group, analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on AFL. TD Cowen restated a “hold” rating on shares of Aflac in a research report on Monday, December 22nd. Wells Fargo & Company lifted their price objective on Aflac from $109.00 to $118.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 25th. Raymond James Financial reissued an “outperform” rating and set a $119.00 price objective (up from $110.00) on shares of Aflac in a research note on Tuesday, December 30th. Mizuho set a $107.00 target price on Aflac in a report on Monday, February 9th. Finally, Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Aflac in a research note on Monday, December 22nd. Three investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Aflac has an average rating of “Hold” and an average target price of $111.73.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. ProShare Advisors LLC lifted its holdings in shares of Aflac by 10.4% in the 3rd quarter. ProShare Advisors LLC now owns 1,731,482 shares of the financial services provider’s stock valued at $193,407,000 after purchasing an additional 163,791 shares during the last quarter. Wedbush Securities Inc. increased its position in Aflac by 126.1% during the third quarter. Wedbush Securities Inc. now owns 21,345 shares of the financial services provider’s stock worth $2,384,000 after buying an additional 11,903 shares during the period. Nordea Investment Management AB increased its position in Aflac by 3.8% during the third quarter. Nordea Investment Management AB now owns 1,768,705 shares of the financial services provider’s stock worth $196,662,000 after buying an additional 65,308 shares during the period. Jones Financial Companies Lllp lifted its stake in Aflac by 12.0% in the third quarter. Jones Financial Companies Lllp now owns 97,344 shares of the financial services provider’s stock valued at $10,841,000 after buying an additional 10,423 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund lifted its stake in Aflac by 31.0% in the third quarter. Oregon Public Employees Retirement Fund now owns 55,022 shares of the financial services provider’s stock valued at $6,146,000 after buying an additional 13,017 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac News Summary

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: New distribution deal: Aflac announced a partnership with Empower Brokerage to distribute supplemental-insurance products, which should broaden channels for sales and support premium growth over time. Read More.
• Neutral Sentiment: Earnings/fundamentals context: Aflac’s Feb. 4 quarter showed an EPS miss and revenue decline year-over-year; consensus remains a “Hold” with an average target around $111. That keeps analysts cautious and caps upside absent clearer improvement in top-line trends.
• Neutral Sentiment: Human-interest coverage: Aflac ran a feature on a policyholder’s cancer journey (brand/PR positive but unlikely to move the stock materially). Read More.
• Negative Sentiment: Director insider sale: Director Charles D. Lake II sold 15,590 shares (avg. ~$109.93) on Mar. 11. Insider sales can be read negatively by the market even if motivated by personal reasons; SEC Form 4 filed. Read More.
• Negative Sentiment: Major shareholder trimming: Post Holdings (Japan) has executed several small block sales (multiple ~17k–19k-share trades across Mar. 5–11). Sales are small relative to its >10% stake but add supply and suggest portfolio rebalancing rather than confidence-boosting buying. Read More.
• Negative Sentiment: Cybersecurity incident disclosed: Media reports say Aflac confirmed a cybersecurity breach; details remain limited. Potential data, remediation costs, regulatory follow-ups or client impact make this the most direct near‑term operational risk in the headlines. Read More.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.